Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Qiagen
AddedFeb 15, 2024
UpdatedJun 28, 2026
Qiagen

Qiagen

Public

QIAGEN N.V., a Netherlands-based medical organization, provides global Sample to Insight solutions for various sectors.

HQ
Venlo, Limburg Province, NL
Founded
1984
Overview
Compare
Employees
Website

Founded on November 29, 1984, QIAGEN N.V. is a Netherlands-based biotechnology company with its corporate headquarters in Venlo and operational headquarters in Hilden, Germany. The company’s core mission is to provide Sample to Insight solutions that transform biological materials into valuable molecular insights. QIAGEN serves a diverse range of markets including Molecular Diagnostics, Applied Testing, Pharma, and Academia, offering products and services that aid in human healthcare, forensics, veterinary testing, food safety, pharmaceutical research, and life sciences research.

Notable affiliated people include founders Metin Colpan, Karsten Henco, and Jürgen Schumacher, with Thierry Bernard serving as CEO and Lawrence A. Rosen as chairman of the supervisory board. QIAGEN is publicly traded on the NYSE and FWB and is a component of the Russell 1000 and DAX indices. The company reported a revenue of $1.97 billion and an operating income of $410 million in 2023. QIAGEN's impact is significant in the biotechnology industry, providing crucial tools and insights that advance scientific research and improve healthcare outcomes globally.

Qiagen - Similar Companies

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Bio-Rad logo

Bio-Rad

bio-rad.com

Quest Diagnostics logo

Quest Diagnostics

Enzo Biochem logo

Enzo Biochem

Myriad Genetics logo

Myriad Genetics

myriad.com

Revvity logo

Revvity

Revvity logo

Revvity

Macrogen logo

Macrogen

Fluidigm logo

Fluidigm

standardbio.com

HTG Molecular Diagnostics logo

HTG Molecular Diagnostics

htgmolecular.com

QuidelOrtho logo

QuidelOrtho

quidelortho.com

Bio-Techne logo

Bio-Techne

Zymo Research logo

Zymo Research

zymoresearch.com

Trinity Biotech logo

Trinity Biotech

trinitybiotech.com

Invitae logo

Invitae

invitae.com

Qiagen - Quick Facts

Who are Qiagen's competitors?

Companies similar to Qiagen include Thermo Fisher th, Bio-Rad, Quest Diagnostics and Enzo Biochem.

When was Qiagen founded?

Qiagen was founded in 1984.

Where is Qiagen's headquarters located?

Qiagen's headquarters is located in Venlo, Limburg Province, NL.

How many employees does Qiagen have?

Qiagen has 6,000 employees as of Feb 6, 2024.

Qiagen - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Molecular Diagnostics
Tags
  • Biotech
Unique IDs
  • ein: 000000000
  • secCik: 0001015820
  • ticker: QGEN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 6420Activities of holding companies